Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

NCT02595866

Conditions
AIDS-Related Non-Hodgkin Lymphoma, Adenocarcinoma, Blood-Borne Infections, +76 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Zuckerberg San Francisco General Hospital San Francisco, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details
Completed

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

NCT00867568

Conditions
Disease Attributes, Glioma, Medulloblastoma, +14 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Arnold Palmer Hospital for Children- MD Anderson Orlando, Florida, United States
  • Cardinal Glennon Children's Medical Center St Louis, Missouri, United States
  • Levine Children's Hospital Charlotte, North Carolina, United States
View Trial Details
Completed

A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT04434196

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Local Institution - 106 Boston, Massachusetts, United States
  • Local Institution - 104 Columbus, Ohio, United States
  • Local Institution - 101 Portland, Oregon, United States
  • Local Institution - 107 Dallas, Texas, United States
View all 15 locations
View Trial Details
Completed

A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma

NCT04154189

Conditions
Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +8 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Benioff Children's Hospitals San Francisco, California, United States
View all 84 locations
View Trial Details
Completed

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

NCT01523977

Conditions
Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • UCSF San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details

Related conditions